SPRY,ARS Pharmaceuticals, Inc. | Healthcare

Healthcare

SPRY

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

ARS Pharmaceuticals, Inc.SPRY

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for patients and parents affected by severe allergic reactions.

It is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for patients and their caregivers with type I allergic reactions, including anaphylaxis.

The company was founded in 2015 and is based in San Diego, California.

Latest News >

TSMC to win more than $5 billion in grants for a US chip plant, Bloomberg reports

Mar 8, 2024

(Reuters) - Taiwan Semiconductor Manufacturing Co ( TSM ) , the world's largest contract chipmaker, is set to win more than $5 billion in federal grants from the U.S. government for setting up a chipmaking plant in Arizona, Bloomberg News reported on Friday. The award is yet to be finalized and it is unclear whether TSMC will tap the loans...

Apple reinstates Epic Games' developer account

Mar 8, 2024

March 8 (Reuters) - Apple ( AAPL ) has reinstated Epic Games' developer account, the Fortnite game maker said on Friday. (Reporting by Akash Sriram in Bengaluru) ...

Core & Main Acquisitions, Volume Gains Drive 2024 Estimates Higher, RBC Says

Mar 8, 2024

12:49 PM EST, 03/08/2024 (MT Newswires) -- Core & Main's ( CNM ) acquisitions and volume gains warrant increased 2024 estimates ahead of the company's fiscal fourth-quarter print for the prior year on March 19, RBC Capital Markets said in a note emailed Friday. The brokerage lifted the water, sewer and fire protection product distributor's price target to $59 from...

A Closer Look at Unity Software's Options Market Dynamics

Mar 8, 2024

Deep-pocketed investors have adopted a bullish approach towards Unity Software ( U ) , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in U usually suggests something big is about to happen. We gleaned this information...